Anti-MelanA antibody [DT101 + BC199] (ab731)

ab731 has been referenced in 10 publications.

• Schwochow Thalmann D  et al. The evolution of Sex-linked barring alleles in chickens involves both regulatory and coding changes in CDKN2A. PLoS Genet 13:e1006665 (2017). IHC-Fr ; Chicken . PubMed: 28388616
• Cao J  et al. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. J Clin Invest 127:349-364 (2017). PubMed: 27918305
• Mi W  et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat Commun 8:1088 (2017). PubMed: 29057918
• Hill DS  et al. A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion. Mol Cancer Ther 14:2665-73 (2015). IHC-P ; Human . PubMed: 26330548
• O'Boyle G  et al. Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070. Br J Cancer 108:1634-40 (2013). PubMed: 23538388
• Krelin Y  et al. Association between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model. PLoS One 8:e62124 (2013). IHC-P ; Mouse . PubMed: 23626777
• Treviño-Villarreal JH  et al. Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma. J Histochem Cytochem 59:1060-75 (2011). IHC-P, Flow Cyt ; Mouse . PubMed: 22147606
• Lindsay CR  et al. P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun 2:555 (2011). PubMed: 22109529
• Blessing K  et al. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 32:139-46 (1998). PubMed: 9543670
• Kageshita T  et al. Differential expression of MART-1 in primary and metastatic melanoma lesions. J Immunother 20:460-5 (1997). PubMed: 9409451